Shunbin Luo
No ORCID on file
· 2 papers in corpus
· active 2021-2022
Study types
- article 2
Condition tags
- endometriosis 2
Top journals
Frequent coauthors
- Chaojie Chen 1
- Er-min Gu 1
- Fuchen Xie 1
- Hongye Yao 1
- Liying Xing 1
- Pingping Luo 1
- Qiong Wang 1
- Ren-ai Xu 1
- Shengling Tang 1
- Tingting Wang 1
article
2022
Relugolix, a gonadotropin-releasing hormone (GnRH) receptor antagonist, has been well studied in the treatment of endometriosis symptomatic. It is mainly metabolized by the CYP3A subfamily of P450 enzymes, while minorly metabolized by CYP2C…
article
2021
Elagolix, as a competitive gonadotropin-releasing hormone (GnRH) receptor antagonist, has been recently approved by the US FDA for the management of moderate to severe pain due to endometriosis in women. In this study, we developed and veri…